Articles
SM04554, a Wnt activator from Samumed, is currently the only new drug worldwide at a phase 3 trial for androgenic alopecia. Last month, Samumed’s CEO Osman Kibar was featured in a Fierce Biotech article which covered Samumed’s various programs for oncology, arthritis, and of course – alopecia. At the end of the article there was…
Read MoreJ. Hewitt, a regenerative medicine company from Japan, has told Follicle Thought they plan to start a pivotal hair multiplication clinical trial in Japan by the end of the year. J.Hewitt & TissUse SHT Collaboration In early 2019, TissUse issued a press release announcing it had granted J. Hewitt of Japan the first license to…
Read More
It’s always pleasing to learn of new companies who are developing drugs to treat hair loss. The more companies there are in the pipeline, the greater the chances are for success. Kintor Pharmaceuticals of China is the latest company to enter the global pharma market of alopecia treatments. Kintor Pharmaceuticals Pipeline There are two listed…
Read More
Aclaris Therapeutics issued a press release on August 8, 2019 which outlined a new direction for their multiple alopecia programs. Additionally, Aclaris recently presented data from its second alopecia areata trial of the year. Looking For Partners There has been a mix of results from Aclaris’ three alopecia trials completed this year. Things started off…
Read MoreAs we get further into the year of 2019 the majority of the online crowd is intently watching for an update from the pivotal RCH-01 trial being sponsored by Shiseido in Japan. Three Years In Japan To recap, back in July 2016, Replicel and Shiseido made headlines by announcing that Shiseido’s trial of the RCH-01…
Read More
Published on: Aug 1, 2019 at 12:32
Read More
2021 Q&A With Dr. Kang-Yell Choi: Update (9/14/21) I was recently able to conduct another Q&A with Dr. Kang-Yell Choi who gives the latest updates on his company below. Among the updates, Dr. Choi’s startup aimed at commercializing drugs which target the CXXC5 protein is now going by a new name, CK Regeon. FT: What’s…
Read More
The hair multiplication company from La Jolla, California has been making headlines all across the internet since its presentation at the ISSCR meeting and the launch of its website in late June 2019. After the initial publication and announcement was released on the Sanford Burnham Prebys website (affiliated organization with Stemson Tx) many articles were…
Read More
In 2016, L’Oreal announced a new research collaboration with the company Poietis who specializes in bioprinting. The purpose of the joint venture was to accomplish the ambitious task of creating a bioprinted hair follicle. In this article I have an update from Poietis on the progress of their hair follicle project. First, let’s take a…
Read More
This article is a continuation of a previous deep dive into one of the most fascinating stories in the biotech industry. The Ziering Study We left off in the previous article with the release of data from Dr. Craig Ziering’s independent trial of HSC. This small study has literally produced the most data we’ve ever…
Read More